Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibodies
Biotech
After $1B fundraise, Xaira breaks silence on AI work
Xaira’s Chief Operating Officer, Jeff Jonker, opened up to Fierce, divulging details about the biotech’s efforts in I&I research.
Gabrielle Masson
,
Darren Incorvaia
Mar 17, 2026 2:52pm
Agilent makes $950M move to acquire Biocare
Mar 11, 2026 3:00pm
BioAtla lays off 70% of workforce, seeks buyers for antibodies
Mar 2, 2026 9:40am
Blood from pediatricians yields new antiviral antibodies
Feb 18, 2026 2:15pm
RoukenBio, AVS Bio partner for predictable antibody development
Feb 17, 2026 3:45pm
CSL inks $328M Memo deal for option on antibody engineering tech
Feb 9, 2026 2:00am